{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:09:02Z","timestamp":1761898142109,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.clinre.2011.07.005","type":"journal-article","created":{"date-parts":[[2011,8,16]],"date-time":"2011-08-16T23:50:42Z","timestamp":1313538642000},"page":"738-744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Therapeutic strategies for severe alcoholic hepatitis"],"prefix":"10.1016","volume":"35","author":[{"given":"Yoshinori","family":"Horie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotoshi","family":"Ebinuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshifumi","family":"Hibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2011.07.005_bib0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cld.2004.11.001","article-title":"Morphology of alcoholic liver disease","volume":"9","author":"Lefkowitch","year":"2005","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinre.2011.07.005_bib0010","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(95)91685-7","article-title":"Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver","volume":"346","author":"Teli","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2011.07.005_bib0015","first-page":"521","article-title":"Treatment of alcoholic hepatitis. A review of randomized trial","volume":"12","author":"Perrot","year":"1988","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.clinre.2011.07.005_bib0020","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S1471-4914(01)02096-2","article-title":"Alcoholic liver disease: new insights into mechanisms and preventative strategies","volume":"7","author":"Stewart","year":"2001","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.clinre.2011.07.005_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.2009.04002.x","article-title":"Review article: the diagnosis and management of alcoholic hepatitis","volume":"30","author":"Cohen","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2011.07.005_bib0030","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1365-2036.2008.03685.x","article-title":"Systematic review: glucocorticosteroids for alcoholic hepatitis\u2013a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials","volume":"27","author":"Rambaldi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2011.07.005_bib0035","first-page":"221","article-title":"Diagnosis and treatment of alcoholic liver disease in Europe. First report","volume":"6","author":"Gluud","year":"1993","journal-title":"Gastroenterol Int"},{"issue":"Suppl. 12","key":"10.1016\/j.clinre.2011.07.005_bib0040","first-page":"251S","article-title":"Severe alcoholic hepatitis in Japan: prognosis and therapy","volume":"29","author":"Horie","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.clinre.2011.07.005_bib0045","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a doubleblind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.07.005_bib0050","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1053\/gast.2000.20826","article-title":"Pentoxifylline and alcoholic hepatitis","volume":"119","author":"Morgan","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.07.005_bib0055","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1572-0241.2004.04034.x","article-title":"Safety and tolerability of etanercept in patients with alcoholic hepatitis","volume":"99","author":"Menon","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.07.005_bib0060","first-page":"137","article-title":"Anti-TNF therapy for severe acute alcoholic hepatitis: what went wrong?","volume":"127","author":"Naveau","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.07.005_bib0065","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis","volume":"135","author":"Boetticher","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2011.07.005_bib0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jhep.2004.04.028","article-title":"Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis","volume":"41","author":"Spahr","year":"2004","journal-title":"J Hepatol"},{"issue":"Suppl. 2","key":"10.1016\/j.clinre.2011.07.005_bib0075","first-page":"7","article-title":"Cytokines and liver failure: modification of TNF-a and IL-6 in patients with acute on chronic liver decompensation treated with molecular adsorbent recycling system (MARS)","volume":"74","author":"Ambrosino","year":"2003","journal-title":"Acta Biomed"},{"key":"10.1016\/j.clinre.2011.07.005_bib0080","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/j.1572-0241.2005.41509.x","article-title":"Immune responses to ethanol metabolites and cytokine profiles differentiate alcoholics with or without liver disease","volume":"100","author":"Latvala","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.07.005_bib0085","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/01926230701584163","article-title":"Role of neutrophils in the pathogenesis of acute inflammatory liver injury","volume":"35","author":"Ramaiahi","year":"2007","journal-title":"Toxicologic Pathol"},{"key":"10.1016\/j.clinre.2011.07.005_bib0090","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.hepres.2006.06.016","article-title":"Granulocytapheresis (GCAP) for severe alcoholic hepatitis- a preliminary report","volume":"36","author":"Kumashiro","year":"2006","journal-title":"Hepatol Res"},{"key":"10.1016\/j.clinre.2011.07.005_bib0095","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1097\/01.ALC.0000078607.32247.9D","article-title":"Severe alcoholic hepatitis successfully treated by leukocytapheresis: a case report","volume":"27","author":"Tsuji","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.clinre.2011.07.005_bib0100","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2169\/internalmedicine.45.1456","article-title":"Severe alcoholic hepatitis with extremely high neutrophil count successfully treated by granulocytapheresis","volume":"45","author":"Okubo","year":"2006","journal-title":"Intern Med"},{"key":"10.1016\/j.clinre.2011.07.005_bib0105","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/MEG.0b013e328332a360","article-title":"Granulocytapheresis in the treatment of severe alcoholic hepatitis: a case series","volume":"22","author":"Morris","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2011.07.005_bib0110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1440-1746.1995.tb01339.x","article-title":"National survey of alcoholic liver disease in Japan (1968\u201391)","volume":"10","author":"Takada","year":"1995","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2011.07.005_bib0115","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1526-0968.2003.00083.x","article-title":"The sequential organ failure assessment score as a useful predictor for estimating the prognosis of systemic inflammatory response syndrome patients being treated with extracorporeal blood purification","volume":"7","author":"Kikuchi","year":"2003","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.clinre.2011.07.005_bib0120","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1526-0968.2004.00149.x","article-title":"Study of plasma exchange for liver failure: beneficial and harmful effects","volume":"8","author":"Abe","year":"2004","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.clinre.2011.07.005_bib0125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.transci.2007.08.003","article-title":"Therapeutic leukocytapheresis for inflammatory bowel disease","volume":"37","author":"Saniabadi","year":"2007","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.clinre.2011.07.005_bib0130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1526-0968.2003.00012.x","article-title":"Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes","volume":"7","author":"Saniabadi","year":"2003","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.clinre.2011.07.005_bib0135","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/j.1572-0241.1998.00587.x","article-title":"Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology","volume":"93","author":"McCullough","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.07.005_bib0140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0168-8278(00)80420-1","article-title":"Alcoholic liver disease: new insights in pathogenesis lead to new treatments","volume":"32","author":"Lieber","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.07.005_bib0145","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.4065\/76.10.1021","article-title":"Pathogenesis, diagnosis, and treatment of alcoholic liver disease","volume":"76","author":"Menon","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinre.2011.07.005_bib0150","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM200011163432007","article-title":"Cytokines in alcoholic and nonalcoholic steatohepatitis","volume":"343","author":"Tilg","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2011.07.005_bib0155","first-page":"A441","article-title":"Clinical and cytokine response to anti-TNF antibody therapy in severe alcoholic hepatitis","volume":"34","author":"Tilg","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.005_bib0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/alcalc\/28.Supplement_1B.97","article-title":"Clinical and pathological features, and the mechanism of development in severe alcoholic hepatitis, especially in comparison with acute type fulminant hepatitis","volume":"1B","author":"Ishii","year":"1993","journal-title":"Alcohol Alcohol Suppl"},{"key":"10.1016\/j.clinre.2011.07.005_bib0165","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0167-5699(95)80066-2","article-title":"The production of cytokines by polymorphonuclear neutrophils","volume":"16","author":"Cassatella","year":"1995","journal-title":"Immunol Today"},{"key":"10.1016\/j.clinre.2011.07.005_bib0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0741-8329(02)00206-9","article-title":"Neutrophilic infiltration in alcoholic hepatitis","volume":"27","author":"Bautista","year":"2002","journal-title":"Alcohol"},{"key":"10.1016\/j.clinre.2011.07.005_bib0175","first-page":"335","article-title":"Chronic alcohol intoxication induces hepatic injury through enhanced macrophage inflammatory protein-2 production and intercellular adhesion molecule-1 expression in the liver","volume":"25","author":"Bautista","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2011.07.005_bib0180","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1172\/JCI119224","article-title":"Hepatic leukostasis and hypoxic stress in adhesion molecule-deficient mice after gut ischemia-reperfusion","volume":"99","author":"Horie","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinre.2011.07.005_bib0185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/gut.15.1.52","article-title":"Studies in alcoholic liver disease in Britain. I. Clinical and pathological patterns related to natural history","volume":"15","author":"Brunt","year":"1974","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2011.07.005_bib0190","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2249.2010.04279.x","article-title":"The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review","volume":"163","author":"Hanai","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clinre.2011.07.005_bib0195","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00011-004-1253-5","article-title":"Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: evidence for the involvement of plasma IgG, complement C3 and beta2 integrin","volume":"53","author":"Takeda","year":"2004","journal-title":"Inflamm Res"},{"key":"10.1016\/j.clinre.2011.07.005_bib0200","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/j.1572-0241.2004.30432.x","article-title":"Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis","volume":"99","author":"Hanai","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.07.005_bib0205","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/MEG.0b013e3282f5e9f3","article-title":"Leucocytapheresis for inflammatory bowel disease in the era of biologic therapy","volume":"20","author":"Hanai","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2011.07.005_bib0210","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.3748\/wjg.v12.i21.3393","article-title":"Effects of adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with active ulcerative colitis","volume":"12","author":"Hanai","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2011.07.005_bib0215","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0168-8278(01)00276-8","article-title":"Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with SAH","volume":"36","author":"Ta\u00efeb","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2011.07.005_bib0220","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1111\/j.1530-0277.1996.tb01708.x","article-title":"Human hepatocyte growth factor in alcoholic liver disease: a comparison with change in alpha-fetoprotein. Department of Veterans Affairs Cooperative Study Group 275","volume":"20","author":"Mendenhall","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.clinre.2011.07.005_bib0225","first-page":"1806","article-title":"Child-Pugh, MELD and Maddrey scores","volume":"6","author":"Gex","year":"2010","journal-title":"Rev Med Suisse"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740111002397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740111002397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:12:06Z","timestamp":1761894726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740111002397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S2210740111002397"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2011.07.005","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic strategies for severe alcoholic hepatitis","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2011.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}